Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular Collaboration
Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular…
Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on genetic epilepsies
Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on…
Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL
Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL Professional audiences…
Healthcare and Pharma Industry Trends H2 2025: From Innovation to Execution
An in-depth analysis of pharma and healthcare industry trends in H2 2025,…
Lucid Diligence Brief: Angitia Biopharmaceuticals $130 million Series D
Lucid Diligence Brief: Angitia Biopharmaceuticals $130 million Series D…
Lucid Diligence Brief: Ultragenyx UX111 BLA resubmission
Lucid Diligence Brief: Ultragenyx UX111 BLA resubmission Professional audiences…
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled rare-disease therapeutics
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled…
Lucid Diligence Brief: Aurora Therapeutics launches to scale personalized CRISPR
Lucid Diligence Brief: Aurora Therapeutics launches to scale personalized…
Respiratory Today—January 9, 2026
This respiratory update spotlights reflects strong momentum across respiratory…
Lucid Diligence Brief: BioMarin to acquire Amicus Therapeutics for $4.8B
Lucid Diligence Brief: BioMarin to acquire Amicus Therapeutics for $4.8B…
Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics
Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics Professional…
Lucid Diligence Brief: Regeneron and Tessera team on TSRA-196 for AATD
Lucid Diligence Brief: Regeneron and Tessera team on TSRA-196 for AATD…